Emergent BioSolutions, Inc. (EBS)
8.24
+0.29
(+3.65%)
USD |
NYSE |
Jun 10, 16:00
8.245
0.00 (0.00%)
After-Hours: 20:00
Emergent BioSolutions Price : 8.24 for June 10, 2026
Price Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Price Data
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Jun 09, 2026 | 8.00 | 8.16 | 7.56 | 7.95 | 818357.0 |
| Jun 08, 2026 | 8.21 | 8.33 | 7.985 | 8.00 | 605400.0 |
| Jun 05, 2026 | 8.38 | 8.51 | 7.95 | 8.07 | 701550.0 |
| Jun 04, 2026 | 8.03 | 8.49 | 8.03 | 8.44 | 935778.0 |
| Jun 03, 2026 | 8.20 | 8.31 | 7.685 | 7.93 | 1.042M |
| Jun 02, 2026 | 8.42 | 8.47 | 8.13 | 8.21 | 802446.0 |
| Jun 01, 2026 | 9.00 | 9.00 | 8.49 | 8.49 | 852282.0 |
| May 29, 2026 | 9.21 | 9.369 | 9.11 | 9.12 | 1.157M |
| May 28, 2026 | 8.90 | 9.40 | 8.78 | 9.18 | 880946.0 |
| May 27, 2026 | 9.22 | 9.340 | 8.97 | 9.00 | 821109.0 |
| May 26, 2026 | 8.54 | 9.285 | 8.52 | 9.13 | 1.085M |
| May 22, 2026 | 8.39 | 8.60 | 8.35 | 8.45 | 986684.0 |
| May 21, 2026 | 8.16 | 8.40 | 8.08 | 8.37 | 554605.0 |
| May 20, 2026 | 8.09 | 8.397 | 8.061 | 8.15 | 614629.0 |
| May 19, 2026 | 8.06 | 8.280 | 7.995 | 8.06 | 671996.0 |
| May 18, 2026 | 8.27 | 8.53 | 8.07 | 8.13 | 863642.0 |
| May 15, 2026 | 8.10 | 8.18 | 7.91 | 7.94 | 508195.0 |
| May 14, 2026 | 8.28 | 8.54 | 8.145 | 8.21 | 598734.0 |
| May 13, 2026 | 8.42 | 8.50 | 8.300 | 8.33 | 574935.0 |
| May 12, 2026 | 8.83 | 8.95 | 8.337 | 8.50 | 606459.0 |
| May 11, 2026 | 9.59 | 9.66 | 8.95 | 8.95 | 633563.0 |
| May 08, 2026 | 9.13 | 9.64 | 9.10 | 9.50 | 982476.0 |
| May 07, 2026 | 9.07 | 9.51 | 9.045 | 9.13 | 654970.0 |
| May 06, 2026 | 9.17 | 9.365 | 9.08 | 9.10 | 664903.0 |
| May 05, 2026 | 8.69 | 9.540 | 8.67 | 9.05 | 1.337M |
Price Definition
The price of a security measures the cost to purchase 1 share of a security. For a company, price can be multiplied by shares outstanding to find the market capitalization (value of the company).
Price Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Price Benchmarks
| ACADIA Pharmaceuticals, Inc. | 21.25 |
| Alnylam Pharmaceuticals, Inc. | 291.27 |
| Savara, Inc. | 5.08 |
| Vericel Corp. | 37.44 |
| Biogen, Inc. | 194.24 |
Price Related Metrics
| PS Ratio | 0.6684 |
| Price to Book Value | 0.8159 |
| Price to Free Cash Flow | 3.341 |
| Earnings Yield | -3.43% |
| Market Cap | 426.83M |
| Operating PE Ratio | 6.354 |